Plymouth, MN, United States of America

Joel Buckley

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Joel Buckley

Introduction

Joel Buckley is a notable inventor based in Plymouth, MN (US), recognized for his significant contributions to the field of therapeutic formulations. With a total of 9 patents to his name, Buckley has focused on developing innovative solutions for medical challenges, particularly in the treatment of fibrotic and connective tissue disorders.

Latest Patents

One of Buckley's latest patents involves the creation of topical therapeutic formulations. This invention provides topical compositions and methods for their application, specifically targeting fibrotic or connective tissue disorders that involve scarring, sub-dermal plaque accumulations, or muscle tissue fibrosis. The compositions are designed to be painlessly applied, utilizing one or more calcium channel blocker agents as active ingredients. Additionally, these formulations may include emu oil and superoxide dismutase, along with pharmaceutically acceptable carriers to facilitate non-invasive transdermal delivery to subdermal sites.

Career Highlights

Throughout his career, Joel Buckley has worked with various companies, including Hybrid Medical, Inc. and Drenaline Products, LLC. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative medical solutions.

Collaborations

Buckley has collaborated with notable individuals in his field, including Harold H. Hoium and Jeffry Twidwell. These partnerships have further enhanced his ability to innovate and create effective therapeutic formulations.

Conclusion

In summary, Joel Buckley is a distinguished inventor whose work in topical therapeutic formulations has the potential to significantly impact the treatment of fibrotic and connective tissue disorders. His innovative approach and dedication to improving medical solutions are commendable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…